- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,549GBP
- Report
- April 2025
- 193 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- July 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- July 2024
- 200 Pages
Global
From €4623EUR$4,949USD£3,911GBP
- Report
- February 2024
- 250 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2023
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- May 2023
- 160 Pages
Global
From €4623EUR$4,949USD£3,911GBP
- Report
- April 2023
- 147 Pages
Global
From €4623EUR$4,949USD£3,911GBP
- Report
- February 2024
- 120 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- October 2023
- 145 Pages
Global
From €2943EUR$3,150USD£2,490GBP
- Report
- March 2021
- 45 Pages
Global
From €2331EUR$2,495USD£1,972GBP
- Report
- March 2023
- 36 Pages
Global
From €1822EUR$1,950USD£1,541GBP
- Report
- January 2024
- 175 Pages
United States
€3550EUR$3,800USD£3,003GBP
- Report
- September 2020
- 65 Pages
Global
€1231EUR$1,318USD£1,042GBP
- Book
- July 2019
North America

Psoriatic Arthritis is a type of inflammatory arthritis that affects individuals with psoriasis, a chronic skin condition. It is a form of spondyloarthropathy, a group of inflammatory joint diseases that affect the spine and other joints. Symptoms of Psoriatic Arthritis include joint pain, stiffness, swelling, and tenderness. It can also cause fatigue, eye inflammation, and nail changes. Treatment options include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biologic agents, and physical therapy.
The Psoriatic Arthritis market is a subset of the Allergy and Immunology market. It is a growing market, driven by the increasing prevalence of psoriasis and the need for effective treatments. The market is expected to benefit from the development of new treatments and the increasing awareness of the condition.
Companies in the Psoriatic Arthritis market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less Read more